Biocon Biologics launches Nepexto, a Biosimilar to Enbrel (Etanercept), in Australia

India's Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has laun...

July 25, 2025 | Friday | News
Japan's Olympus enters strategic partnership to develop endoluminal gastrointestinal robotics

Japan-based medtech company Olympus Corporation has signed a partnership with Revival Healthcare Capital to advance endo...

July 25, 2025 | Friday | News
MilliporeSigma and Washington University sign MoU to advance scientific collaboration

MilliporeSigma, the US and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technol...

July 25, 2025 | Friday | News
Asia’s Biotech Ambitions Amplified on Day 2 of BIO Asia–Taiwan 2025

Day 2 of BIO Asia–Taiwan 2025 unfolded with palpable energy and a heightened sense of purpose as stakeholders from...

July 25, 2025 | Friday | News
Bora Health partners with Dr. Reddy’s Labs to address unmet medical needs in Taiwan

Bora Health, subsidiary of SunWay Biotech which focuses on pharmaceutical distribution and sales in Taiwan, has entered ...

July 24, 2025 | Thursday | News
Japan's Eisai launches Beova tablets in Thailand for treating overactive bladder

Japan-based Eisai Co. and Kyorin Pharmaceutical Co. have announced that Eisai (Thailand) Marketing Co., a subsidiary of ...

July 24, 2025 | Thursday | News
Cenra Healthcare and Dr. Reddy's to expand access to medicines in Taiwan

Cenra Healthcare, the sales and marketing arm of Cenra Inc., has announced the deepening of its long-standing collaborat...

July 23, 2025 | Wednesday | News
AstraZeneca plans to invest $50 B in America for medicines manufacturing and R&D

AstraZeneca has announced $50 billion of investment in the United States by 2030, building on America’s global lea...

July 22, 2025 | Tuesday | News
Shanghai Healthcare M&A Fund strategically acquires Chengdu Kanghua Biological

Chengdu Kanghua Biological Products Co. has announced that Shanghai Healthcare M&A Fund intends to acquire the compa...

July 22, 2025 | Tuesday | News
Health2Sync and Novo Nordisk enhance insulin administration via digital diabetes care in Korea

Health2Sync, Asia's leading digital chronic disease management platform, has announced the successful integration of Sma...

July 9, 2025 | Wednesday | News
Taiwan advances precision oncology landscape with new bioinformatics platform

Inocras Inc., a global leader in whole-genome sequencing (WGS) and bioinformatics, has announced the signing of a Memora...

July 8, 2025 | Tuesday | News
WuXi XDC accelerates global expansion of bioconjugates manufacturing by revitalising Singapore site

WuXi XDC Cayman Inc. a leading global Contract Research, Development and Manufacturing Organisation (CRDMO) focused on t...

July 2, 2025 | Wednesday | News
Lonza leaders on manufacturing readiness: Meeting the cell and gene therapy challenge

Cell and gene therapies are reshaping the landscape of modern medicine—but bringing these transformative treatment...

July 2, 2025 | Wednesday | Opinion
Gero’s ProtoBind‑Diff redefines drug discovery by designing molecules from sequence alone

BioSpectrum Asia spoke to Dr Peter Fedichev, CEO of Gero, who explains how ProtoBind-Diff is transforming drug discovery...

July 2, 2025 | Wednesday | Opinion
Korea's Seegene launches STAgora, new platform for infectious disease analytics

South Korea-based Seegene Inc., a global leader in molecular diagnostics (MDx) solutions, has announced the launch of ST...

July 2, 2025 | Wednesday | News
China's WuXi Biologics launches next-generation platform for high-concentration biologics

WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organisation (CRDMO) in China, has an...

July 1, 2025 | Tuesday | News
Medical Advances Soar With APAC’s Clinical Trial Growth

It’s universally acknowledged that Asia-Pacific (APAC) is a hotbed for clinical trials, with multiple reports conf...

July 1, 2025 | Tuesday | Analysis
Australia's Neurizon develops liquid formulation of NUZ-001 for treatment of Amyotrophic Lateral Sclerosis

Neurizon Therapeutics, a clinical-stage biotech company based in Australia, has announced the development of a new oral ...

June 30, 2025 | Monday | News